Treatment of diffuse large-cell lymphoma with anti-CD20 antibody

Treatment of pemphigus

Treatment of diffuse large-cell lymphoma with anti-CD20 antibody

Treatment of diffuse large-cell lymphoma with anti-CD20 antibody

Agonist antibody to human thrombopoietin receptor

TREATMENT OF MULTIPLE SCLEROSIS

CD20-binding polypeptide compositions for treating autoimmune disease

Agonist antibody to human thrombopoietin receptor

Anti-αβantibodies and uses thereof

HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES

Treatment of Autoimmune Diseases

Treatment of vasculitis

Treatment of Autoimmune Diseases

Treatment of Autoimmune Diseases

Avian derived antibodies

Antibodies against interleukin-1 β

Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such

Agonist antibody to human thrombopoietin receptor

Anti-αβantibodies and uses thereof

Anti-CD20 antibodies

Antibodies against interleukin-1β

Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies

Treatment with anti-ErbB2 antibodies and chemotherapeutic agents

Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies

Treatment with anti-ErbB2 antibodies and anti-hormonal compounds

Treatment with anti-ErbB2 antibody combinations

Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof

Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies

Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma

Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in

CD20-binding polypeptide compositions and methods

Rupestris stem pitting associated virus nucleic acids, proteins, and their uses

Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody